Chitosan and trimethyl chitosan particles as oral vaccine delivery systems: Comparison of the potential to initiate immune responses


  • Supavadee Boontha Faculty of Pharmaceutical Sciences, Naresuan University
  • Hans E. Unginger Faculty of Pharmaceutical Sciences, Naresuan University
  • Neti Waranuch Faculty of Pharmaceutical Sciences, Naresuan University
  • Assadang Polnok Faculty of Pharmaceutical Sciences, Naresuan University
  • Tasana Pitaksuteepong Faculty of Pharmaceutical Sciences, Naresuan University


Chitosan, Trimethyl chitosan, Oral vaccine, Immune responses


In this study, particles having low MW (Chi-L), high MW (Chi-H) and their respective trimethyl chitosan (TMC) with a degree of quaternization (DQ) of about 40% (TMC-L-40 and TMC-H-40), and prepared by using chitosan, were used to compare their potentials for provoking immune responses to ovalbumin (OVA) following oral administration. The results showed that the Chi-L particles gave higher serum immunoglobulin G (IgG) responses to OVA than those induced with Chi-H, TMC-L-40 and TMC-H-40 particles. However, Chi-L and Chi-H particles gave similar secretory immunoglobulin A (sIgA) to OVA, and sIgA titers obtained from mice immunized with OVA-loaded TMC were negligible. This study demonstrated that chitosan particles seem to be better delivery systems for oral vaccination, and the MW of chitosan appeared to have an effect on the ability to elicit immune responses to OVA in BALB/c mice following oral immunization.


Download data is not yet available.


Norris, D.A., Puri, N. & Sinko, P. (1998). The effect of physical barriers and properties on the oral absorption of particulates. Adv. Drug Deliver. Rev. 34(2-3): 135-154. 0 50 100 150 200 250 Week 2 Week 3 Week 4 IgA (ng/ml) Solution Chi-L Chi-H TMC-L-40 TMC-H-40 Alum * *

O’Hagan, D.T. (1998). Microparticles and polymers for the mucosal delivery of vaccines. Adv. Drug Deliver. Rev. 34(2-3): 305-320.

Van der Lubben, I.M., Kersten, G., Fretz, M.M., Beuvery, C., Verhoef, J.C. & Junginger, H.E. (2003). Chitosan microparticles for mucosal vaccination against diphtheria: oral and nasal efficacy studies in mice. Vaccine. 21(13-14): 1400-1408.

Delie, F. & Blanco-Prieto, M.J. (2005). Polymeric particulates to improve oral bioavailability of peptide drug. Molecules. 10(1): 65-80.

Illum, L. (1998). Chitosan and its use as a pharmaceutical excipient. Pharm. Res. 15(9): 1326-1331.

Davis, S.S. (2006). The use of soluble polymers and polymer microparticles to provide improved vaccine responses after parenteral and mucosal delivery. Vaccine. 24 Supplement2: S7-S10.

The Thai Frozen Foods Association (TFFA) (2009). Newsletter December: 1-24.

Barreteau, H., Delattre, C. & Michaud, P. (2006). Production of Oligosaccharides as Promising New Food Aditive Generation. Food Technol. Biotech 44: 323-333.

Kotzé, A.F., De Leeuw, B.J., Luessen, H.L., De Boer, A.G., Verhoef, J.C. & Junginger, H.E. (1997a.). Chitosan for enhanced delivery of therapeutic peptides across intestinal epithelia: In vitro evaluation in Caco-2 cell monolayer. Int. J. Pharm. 159(2): 243-253.

Van der Merwe, S.M., Verhoef, J.C., Verheijden, J.H.M., Kotzé, A.F. & Junginger, H.E. (2004). Trimethylated chitosan as polymeric absorption enhancer for improved peroral delivery of peptide drugs. Eur. J. Pharm. Biopharm. 58(2): 225-235.

Kotzé, A.F., Lueßen, H.L., De Leeuw, B.J., De Boer A.G., Verhoef, J.C. & Junginger, H.E. (1997 b). N-trimethyl chitosan chloride as a potential absorption enhancer across mucosal surfaces: In vitro evaluation in intestinal epithelial cells (Caco-2). Pharm. Res. 14(9): 1197-1202.

Sandri, G., Bonferoni M.C., Rossi, S., Ferrari, F., Gibin, S., Zambito, Y., Di Colo, G. & Caramella, C. 2007. Nanoparticles based on N-trimethylchitosan: Evaluation of absorption properties using in vitro (Caco- 2 cells) and ex vivo (excised rat jejunum) models. Eur. J. Pharm. Biopharm. 65(1): 68-77.

Boonyo, W., Junginger, H.E., Waranuch, N., Polnok, A. & Pitaksuteepong, T. (2007). Chitosan and trimethyl chitosan chloride (TMC) as adjuvants for inducing immune responses to ovalbumin in mice following nasal administration. J. Control. Release 121(3): 168-175.

Vila, A., Sánchez, A., Janes, K., Behrens, I., Kissel, T., Jato, J.L.V. & Alonso, M.J. (2004). Low molecular weight chitosan nanoparticles as new carries for nasal vaccine delivery in mice. Eur. J. Pharm. Biopharm. 57(1): 123-131.

Pitaksuteepong, T. (2003). Potential of mediumchain glycerides-based microemulsions for provoking immune response following oral administration. Naresuan University Journal. 11(2): 49-59.

Boontha, S., Junginger, H.E., Waranuch, N., Polnok, A. & Pitaksuteepong, T. (2010) Formation of particles prepared using chitosan and their trimethyl chitosan derivatives for oral vaccine delivery: Effect of molecular weight and degree of quaternization, Songklanakarin J. Sci. Technol. 32(4): 363-371.

Jintapattanakit, A., Junyaprasert, V.B., Mao, S., Sitterberg, J., Bakowsky, U. & Kissel, T. (2007). Peroral delivery of insulin using chitosan derivatives: A comparative study of polyelectrolyte nanocomplex and nanoparticles. Int. J. Pharm. 342(1-2): 240- 249.

Coombes, A.G.A., Lavelle, E.C., Jenkins, P.G. & Davis, S.S. (1996). Single dose, polymeric, microparticle-based vaccines: the influence of formulation conditions on the magnitude and duration of the immune response to a protein antigen. Vaccine 14(15): 1429- 1438.

des Rieux, A., Fievez, V., Garinot, M., Schneider Y.J. & Préat, V. (2006). Nanoparticles as potential oral delivery systems of proteins and vaccines: A mechanistic approach. J. Control. Release 116(1): 1–27.




How to Cite

S. Boontha, H. E. . Unginger, N. . Waranuch, A. Polnok, and T. Pitaksuteepong, “Chitosan and trimethyl chitosan particles as oral vaccine delivery systems: Comparison of the potential to initiate immune responses”, J Met Mater Miner, vol. 21, no. 1, Jun. 2011.



Original Research Articles